UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023090
Receipt number R000026610
Scientific Title A single-institutional study for the efficacy and optimal dose and method of Japanese herbal medicine in pediatric patients
Date of disclosure of the study information 2016/07/11
Last modified on 2017/07/10 11:28:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A single-institutional study for the efficacy and optimal dose and method of Japanese herbal medicine in pediatric patients

Acronym

A single-institutional study of Japanese herbal medicine in pediatric patients

Scientific Title

A single-institutional study for the efficacy and optimal dose and method of Japanese herbal medicine in pediatric patients

Scientific Title:Acronym

A single-institutional study of Japanese herbal medicine in pediatric patients

Region

Japan


Condition

Condition

Pediatric diseases

Classification by specialty

Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the efficacy and safety of Japanese herbal medicine in pediatric patients

Basic objectives2

Others

Basic objectives -Others

Efficacy, safety, medication adherence, optimal method, and consciousness survey

Trial characteristics_1

Others

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Efficacy

Key secondary outcomes

Safety, medication adherence, optimal method, consciousness, and survey


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

0 years-old <=

Age-upper limit

20 years-old >=

Gender

Male and Female

Key inclusion criteria

1. All patients with pediatric surgical disease, visiting our outpatient clinic or hospitalized in our institute.
2. All patients are required to give written informed consent prior to enrolment in the study.
3. Patients who are under 10 years old are required to give written informed consent from proxy.
4. Patients who are aged over 10 years and below 20 years are required to give written informed assent and written informed consent from proxy.

Key exclusion criteria

1. Known allergy or contraindication to Japanese herbal medicine
2.Patients whom investigators consider to be ineligible

Target sample size

700


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kohei Otake

Organization

Mie University Graduate School of Medicine

Division name

Department of Gastrointestinal and Pediatric Surgery

Zip code


Address

Edobashi 2-174, Tsu, Mie 514-8507, JAPAN

TEL

059-232-1111(5645)

Email

kohei815@clin.medic.mie-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kohei Otake

Organization

Mie University Graduate School of Medicine

Division name

Department of Gastrointestinal and Pediatric Surgery

Zip code


Address

Edobashi 2-174, Tsu, Mie 514-8507, JAPAN

TEL

059-232-1111(5645)

Homepage URL


Email

kohei815@clin.medic.mie-u.ac.jp


Sponsor or person

Institute

Mie University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

The lead principal investigator moved to another hospital in April 2017. Thus, this study was impossible to continue in the Mie university hospital.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2016 Year 04 Month 21 Day

Date of IRB


Anticipated trial start date

2016 Year 07 Month 11 Day

Last follow-up date

2017 Year 03 Month 31 Day

Date of closure to data entry

2017 Year 03 Month 31 Day

Date trial data considered complete

2017 Year 03 Month 31 Day

Date analysis concluded

2017 Year 03 Month 31 Day


Other

Other related information

Prospective and retrospective observational study


Management information

Registered date

2016 Year 07 Month 09 Day

Last modified on

2017 Year 07 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026610


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name